IB, S., A, G., PJ, G., L, W., J, H., J, H., . . . A, W. (2022). Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial. Clinical and translational science, 15(10), 2493. https://doi.org/10.1111/cts.13377
Chicago Style (17th ed.) CitationIB, Squire, et al. "Effect of AZD9977 and Spironolactone on Serum Potassium in Heart Failure with Preserved or Mildly Reduced Ejection Fraction, and Renal Impairment: A Randomized Trial." Clinical and Translational Science 15, no. 10 (2022): 2493. https://doi.org/10.1111/cts.13377.
MLA (9th ed.) CitationIB, Squire, et al. "Effect of AZD9977 and Spironolactone on Serum Potassium in Heart Failure with Preserved or Mildly Reduced Ejection Fraction, and Renal Impairment: A Randomized Trial." Clinical and Translational Science, vol. 15, no. 10, 2022, p. 2493, https://doi.org/10.1111/cts.13377.